Glenview Capital Management

Glenview Capital Management is a hedge fund founded in 2000 by Larry Robbins, who serves as CEO and portfolio manager. The firm manages capital for investors through a series of private investment funds, focusing on delivering long-term capital appreciation by employing a fundamental research approach and taking concentrated positions in companies it believes are undervalued. As of March 2019, Glenview managed approximately $7.7 billion in assets.

The firm's investment strategy is commonly related to Growth at a Reasonable Price (GARP). Glenview focuses on companies in stable industries with recurring revenue streams or entrenched market positions. The firm primarily focuses on investments in the healthcare, consumer, and industrial sectors but maintains a diversified portfolio across various industries and geographies. Glenview employs a long/short strategy focused on investments in equity and fixed income securities.

Glenview has a history of active engagement with portfolio companies to influence positive changes and enhance shareholder value. In 2013, the firm placed number one on the Bloomberg Markets annual ranking of best-performing large hedge funds due to the Glenview Capital Opportunity Fund, which saw an 84% gain through October 2013. The firm has also been involved in significant corporate actions, such as advocating for changes in the merger plans of Dow Chemical and DuPont in 2017 and supporting Cigna's acquisition of Express Scripts in 2018.